Achyoot Sharan Koirala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Achyoot Sharan Koirala has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Parishrut Prasad Pandey
Kathmandu University
2 shared publications - Ujjwal Kumar Mbbs Shah
Medical Intensive Care Unit, College of Medical Sciences, Bharatpur, Chitwan, Nepal
2 shared publications - Aakash Acharya
Centinela Hospital Medical Center Inglewood California USA
1 shared publication Aashish Lamichhane
MBBS Intern, Bharatpur, 44200, Nepal
1 shared publicationAlok Kumar Jha
Neurology, College of Medical Sciences Teaching Hospital, Bharatpur, Central Development Region, Nepal
1 shared publication- Amit Khanal
Atrium Health Wake Forest Baptist, NC
1 shared publication
Latest Publications
- 19 November 2026
- Published by Wiley in Journal of Hospital Medicine
Structured communication and transitional‐care interventions across hospital‐skilled nursing facility transitions: A scoping review
Background: Communication failures and fragmented follow‐up can compromise care during transitions between hospitals and skilled nursing facilities (SNFs). Available programs differ in setting, transition direction, components, implementation, and outcomes, making it difficult to identify a single best approach. Objective: To map structured communication and transitional‐care interventions involving hospital‐SNF transitions, describe the reported outcome evidence, and identify gaps for future research. Methods: We conducted a scoping review of randomized, quasi‐experimental, observational, quality‐improvement, and descriptive studies involving adult hospital‐SNF transitions. CENTRAL, CINAHL, Embase, Google Scholar, MEDLINE, PubMed, and Scopus were searched from database inception through March 11, 2026. Data were charted on transition direction, intervention or process components, study design, comparator availability, outcomes, and implementation characteristics. Findings were mapped descriptively; no pooled effect estimate was calculated. Results: Seven US reports met the inclusion criteria: one cluster‐randomized trial, four observational or quality‐improvement evaluations, and two descriptive transition analyses. Reported components included structured cross‐setting communication, early clinician assessment, care‐plan review, medication reconciliation, pharmacist involvement, caregiver education, and escalation pathways. The only cluster‐randomized implementation trial found no statistically significant reduction in major acute‐care outcomes. Reporting of mortality, post‐discharge disposition, costs, caregiver‐centered outcomes, contemporary digital tools, and long‐term implementation was sparse or absent. Conclusions: This scoping review identifies a small, heterogeneous evidence base and does not establish which transition intervention reduces readmissions. The literature suggests potential value in addressing communication and continuity failures, but direct, contemporary comparative studies with patient‐centered and implementation outcomes are needed. Trial Registration: The original protocol was registered in PROSPERO (CRD420261388654). The final report is presented as a scoping review because its objective is evidence mapping rather than pooled effect estimation.
- 19 November 2026
- Published by Wiley in Journal of Hospital Medicine
Structured communication and transitional‐care interventions across hospital‐skilled nursing facility transitions: A scoping review
Background: Communication failures and fragmented follow‐up can compromise care during transitions between hospitals and skilled nursing facilities (SNFs). Available programs differ in setting, transition direction, components, implementation, and outcomes, making it difficult to identify a single best approach. Objective: To map structured communication and transitional‐care interventions involving hospital‐SNF transitions, describe the reported outcome evidence, and identify gaps for future research. Methods: We conducted a scoping review of randomized, quasi‐experimental, observational, quality‐improvement, and descriptive studies involving adult hospital‐SNF transitions. CENTRAL, CINAHL, Embase, Google Scholar, MEDLINE, PubMed, and Scopus were searched from database inception through March 11, 2026. Data were charted on transition direction, intervention or process components, study design, comparator availability, outcomes, and implementation characteristics. Findings were mapped descriptively; no pooled effect estimate was calculated. Results: Seven US reports met the inclusion criteria: one cluster‐randomized trial, four observational or quality‐improvement evaluations, and two descriptive transition analyses. Reported components included structured cross‐setting communication, early clinician assessment, care‐plan review, medication reconciliation, pharmacist involvement, caregiver education, and escalation pathways. The only cluster‐randomized implementation trial found no statistically significant reduction in major acute‐care outcomes. Reporting of mortality, post‐discharge disposition, costs, caregiver‐centered outcomes, contemporary digital tools, and long‐term implementation was sparse or absent. Conclusions: This scoping review identifies a small, heterogeneous evidence base and does not establish which transition intervention reduces readmissions. The literature suggests potential value in addressing communication and continuity failures, but direct, contemporary comparative studies with patient‐centered and implementation outcomes are needed. Trial Registration: The original protocol was registered in PROSPERO (CRD420261388654). The final report is presented as a scoping review because its objective is evidence mapping rather than pooled effect estimation.
- Open Access
- 21 August 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (9) , 6042-6047
Favorable outcome in paraquat poisoning with acute kidney injury in a resource-limited setting: a case report
Introduction and importance: Paraquat poisoning remains a major public health challenge in Asia, with a mortality rate of 60%–80%, and acute kidney injury being a common complication. Case presentation: An 18-year-old female presented 6 hours after ingestion of approximately 5 mL of 24% (1.2 g) paraquat. Gastric lavage was performed within 30 minutes. She developed oral mucosal ulcers, dysphagia, and progressive AKI with serum creatinine rising from 1.0 mg/dL on the day of admission to 7.3 mg/dL by day 6 (eGFR declining from 83.7 mL/min/1.73m 2 to 7.7 mL/min/1.73 m 2 ). Chest radiography on day 3 showed prominent bronchovascular markings, and liver enzymes were significantly elevated. Despite indications for hemodialysis, it was not performed due to financial constraints. The patient was managed with intensive supportive care, including corticosteroids, N-acetylcysteine, antibiotics, proton pump inhibitors, and fluid resuscitation. Three-month follow-up showed no respiratory, gastrointestinal, or renal manifestations. Clinical discussion: Favorable prognostic factors included young age, rapid gastric decontamination, a moderate ingested dose (26 mg/kg), relatively preserved initial renal function, and early, aggressive supportive therapy. Conclusion: This case demonstrates that survival is possible in cases of moderate-dose paraquat poisoning with AKI, even without hemodialysis, when early supportive care is promptly initiated. While this single case cannot be generalized, it highlights the critical importance of rapid decontamination and aggressive supportive management in resource-limited settings where paraquat remains readily accessible, and it underscores the need for further research to develop affordable, evidence-based treatment protocols for paraquat poisoning in developing countries.
- 21 August 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (9) , 6042-6047
Open AccessFavorable outcome in paraquat poisoning with acute kidney injury in a resource-limited setting: a case report
Introduction and importance: Paraquat poisoning remains a major public health challenge in Asia, with a mortality rate of 60%–80%, and acute kidney injury being a common complication. Case presentation: An 18-year-old female presented 6 hours after ingestion of approximately 5 mL of 24% (1.2 g) paraquat. Gastric lavage was performed within 30 minutes. She developed oral mucosal ulcers, dysphagia, and progressive AKI with serum creatinine rising from 1.0 mg/dL on the day of admission to 7.3 mg/dL by day 6 (eGFR declining from 83.7 mL/min/1.73m 2 to 7.7 mL/min/1.73 m 2 ). Chest radiography on day 3 showed prominent bronchovascular markings, and liver enzymes were significantly elevated. Despite indications for hemodialysis, it was not performed due to financial constraints. The patient was managed with intensive supportive care, including corticosteroids, N-acetylcysteine, antibiotics, proton pump inhibitors, and fluid resuscitation. Three-month follow-up showed no respiratory, gastrointestinal, or renal manifestations. Clinical discussion: Favorable prognostic factors included young age, rapid gastric decontamination, a moderate ingested dose (26 mg/kg), relatively preserved initial renal function, and early, aggressive supportive therapy. Conclusion: This case demonstrates that survival is possible in cases of moderate-dose paraquat poisoning with AKI, even without hemodialysis, when early supportive care is promptly initiated. While this single case cannot be generalized, it highlights the critical importance of rapid decontamination and aggressive supportive management in resource-limited settings where paraquat remains readily accessible, and it underscores the need for further research to develop affordable, evidence-based treatment protocols for paraquat poisoning in developing countries.
- Open Access
- 30 June 2026
- Published by Nepal Journals Online (JOL) in Journal of Bharatpur Hospital
- Vol. 2 (1) , 109-115
A Patient With Chronic Cough And Fever: A Case Of Extensive Sarcoidosis; A Notorious Mimicker Of Tuberculosis
Background: Sarcoidosis is a chronic systemic granulomatous disease that closely mimics tuberculosis (TB) in clinical, radiological, and histopathological features. In TB-endemic regions like Nepal, this overlap frequently leads to misdiagnosis and delayed appropriate treatment. Case Presentation: A 53-year-old male construction worker from India presented with 8–9 months of intermittent cough, low-grade fever, mild chest pain, and exertional dyspnea (MMRC Grade II). He had a history of TB contact and had already completed 8 months of anti-tubercular therapy (ATT) with incomplete and transient improvement. Investigations showed elevated ESR, negative sputum Gene Xpert, negative Mantoux test, and restrictive pattern on spirometry. CT chest revealed bilateral consolidation, fibrotic bands, fine nodules, and ground glass opacities. Bronchoscopy with BAL showed airway inflammation and an elevated CD4:CD8 ratio. CT-guided lung biopsy confirmed non-caseating granulomas with extensive fibrosis, establishing a diagnosis of pulmonary sarcoidosis (Scadding Stage IV). The patient responded well to pulse methylprednisolone followed by oral prednisolone, with significant symptomatic improvement at two-week follow-up. Conclusion: This case underscores the need to maintain sarcoidosis as an active differential diagnosis in TB-endemic settings, particularly when clinical response to ATT is suboptimal. Histopathological confirmation remains essential to avoid prolonged, inappropriate treatment
- 30 June 2026
- Published by Nepal Journals Online (JOL) in Journal of Bharatpur Hospital
- Vol. 2 (1) , 109-115
Open AccessA Patient With Chronic Cough And Fever: A Case Of Extensive Sarcoidosis; A Notorious Mimicker Of Tuberculosis
Background: Sarcoidosis is a chronic systemic granulomatous disease that closely mimics tuberculosis (TB) in clinical, radiological, and histopathological features. In TB-endemic regions like Nepal, this overlap frequently leads to misdiagnosis and delayed appropriate treatment. Case Presentation: A 53-year-old male construction worker from India presented with 8–9 months of intermittent cough, low-grade fever, mild chest pain, and exertional dyspnea (MMRC Grade II). He had a history of TB contact and had already completed 8 months of anti-tubercular therapy (ATT) with incomplete and transient improvement. Investigations showed elevated ESR, negative sputum Gene Xpert, negative Mantoux test, and restrictive pattern on spirometry. CT chest revealed bilateral consolidation, fibrotic bands, fine nodules, and ground glass opacities. Bronchoscopy with BAL showed airway inflammation and an elevated CD4:CD8 ratio. CT-guided lung biopsy confirmed non-caseating granulomas with extensive fibrosis, establishing a diagnosis of pulmonary sarcoidosis (Scadding Stage IV). The patient responded well to pulse methylprednisolone followed by oral prednisolone, with significant symptomatic improvement at two-week follow-up. Conclusion: This case underscores the need to maintain sarcoidosis as an active differential diagnosis in TB-endemic settings, particularly when clinical response to ATT is suboptimal. Histopathological confirmation remains essential to avoid prolonged, inappropriate treatment
- Open Access
- 17 June 2026
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20 (1)
Chronic tophaceous gout in a 72-year-old male presenting with fatal hypertensive hemorrhagic stroke: a case report
Chronic tophaceous gout is a well-recognized consequence of long-standing hyperuricemia. Although epidemiological evidence increasingly links hyperuricemia with elevated cerebrovascular risk, the co-occurrence of advanced tophaceous gout and fatal hemorrhagic stroke is infrequently reported, particularly from South Asian populations. A 72-year-old Nepali male with a 15-year history of hypertension and a 12-year history of poorly controlled gouty arthritis presented following a fall with decreased consciousness. He was in hypertensive crisis (200/100 mmHg) with a Glasgow Coma Scale of 11/15 and left-sided hemiparesis. Physical examination incidentally revealed extensive subcutaneous tophi at bilateral elbows, left second metacarpophalangeal joint, bilateral first metatarsophalangeal joints, right Achilles tendon, and bilateral knees. Investigations showed hyperuricemia (serum uric acid 10.2 mg/dL), mildly elevated creatinine (peak 1.8 mg/dL), a normal coagulation profile, and absence of thrombocytopenia (platelets 172,000/μL). HbA1c was 5.1%, excluding diabetes. Neuroimaging confirmed a right thalamic hemorrhage with intraventricular extension. Despite ICU management, he deteriorated neurologically and was discharged against medical advice. He died five days after discharge. This fatal hemorrhagic stroke occurred in a patient with coexisting advanced tophaceous gout and long-standing hypertension. While the stroke was attributable to hypertensive crisis, the incidental finding of extensive tophi highlights the systemic burden of uncontrolled hyperuricemia. The case underscores the importance of sustained urate-lowering therapy and cardiovascular risk management in patients with gout, and the serious consequences of medication non-adherence.
- 17 June 2026
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20 (1)
Open AccessChronic tophaceous gout in a 72-year-old male presenting with fatal hypertensive hemorrhagic stroke: a case report
Chronic tophaceous gout is a well-recognized consequence of long-standing hyperuricemia. Although epidemiological evidence increasingly links hyperuricemia with elevated cerebrovascular risk, the co-occurrence of advanced tophaceous gout and fatal hemorrhagic stroke is infrequently reported, particularly from South Asian populations. A 72-year-old Nepali male with a 15-year history of hypertension and a 12-year history of poorly controlled gouty arthritis presented following a fall with decreased consciousness. He was in hypertensive crisis (200/100 mmHg) with a Glasgow Coma Scale of 11/15 and left-sided hemiparesis. Physical examination incidentally revealed extensive subcutaneous tophi at bilateral elbows, left second metacarpophalangeal joint, bilateral first metatarsophalangeal joints, right Achilles tendon, and bilateral knees. Investigations showed hyperuricemia (serum uric acid 10.2 mg/dL), mildly elevated creatinine (peak 1.8 mg/dL), a normal coagulation profile, and absence of thrombocytopenia (platelets 172,000/μL). HbA1c was 5.1%, excluding diabetes. Neuroimaging confirmed a right thalamic hemorrhage with intraventricular extension. Despite ICU management, he deteriorated neurologically and was discharged against medical advice. He died five days after discharge. This fatal hemorrhagic stroke occurred in a patient with coexisting advanced tophaceous gout and long-standing hypertension. While the stroke was attributable to hypertensive crisis, the incidental finding of extensive tophi highlights the systemic burden of uncontrolled hyperuricemia. The case underscores the importance of sustained urate-lowering therapy and cardiovascular risk management in patients with gout, and the serious consequences of medication non-adherence.
- Open Access
- 1 January 2026
- Published by BMJ in BMJ Neurology Open
- Vol. 8 (1) , e001511
Bilateral thalamic involvement in scrub typhus meningoencephalitis: a case report of an uncommon neuroimaging pattern mimicking Japanese encephalitis
Background: Scrub typhus is a major but under-recognised cause of acute febrile illness in Southeast Asia. Neurological involvement occurs in up to 20% of cases, but bilateral thalamic lesions, which are classically associated with Japanese encephalitis (JE), are rare in scrub typhus. Case presentation: A 45-year-old woman presented during the monsoon season with high-grade fever, altered mental status and generalised tonic-clonic seizure. MRI revealed bilateral symmetric thalamic T2/FLAIR hyperintensities with diffusion restriction, initially raising strong suspicion for JE. Serological testing showed positive scrub typhus IgM/IgG and negative JE IgM. Lumbar puncture was deferred due to raised intracranial pressure. She was managed with intravenous doxycycline, ceftriaxone, acyclovir (later discontinued), hypertonic saline, corticosteroids and supportive ICU care. Conclusion: This case highlights a rare neuroimaging manifestation of scrub typhus that closely mimics JE. In endemic regions, scrub typhus should be considered in febrile neurological illness even in the absence of eschar or typical imaging findings.
- 1 January 2026
- Published by BMJ in BMJ Neurology Open
- Vol. 8 (1) , e001511
Open AccessBilateral thalamic involvement in scrub typhus meningoencephalitis: a case report of an uncommon neuroimaging pattern mimicking Japanese encephalitis
Background: Scrub typhus is a major but under-recognised cause of acute febrile illness in Southeast Asia. Neurological involvement occurs in up to 20% of cases, but bilateral thalamic lesions, which are classically associated with Japanese encephalitis (JE), are rare in scrub typhus. Case presentation: A 45-year-old woman presented during the monsoon season with high-grade fever, altered mental status and generalised tonic-clonic seizure. MRI revealed bilateral symmetric thalamic T2/FLAIR hyperintensities with diffusion restriction, initially raising strong suspicion for JE. Serological testing showed positive scrub typhus IgM/IgG and negative JE IgM. Lumbar puncture was deferred due to raised intracranial pressure. She was managed with intravenous doxycycline, ceftriaxone, acyclovir (later discontinued), hypertonic saline, corticosteroids and supportive ICU care. Conclusion: This case highlights a rare neuroimaging manifestation of scrub typhus that closely mimics JE. In endemic regions, scrub typhus should be considered in febrile neurological illness even in the absence of eschar or typical imaging findings.